Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Korde

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Current Hematologic Malignancy Reports|February 20, 2016
Smoldering Multiple Myeloma: Emerging Concepts and TherapeuticsSrinath Sundararajan, Abhijeet Kumar, Neha Korde, et al.
Clinical Advances in Hematology & Oncology : H&O|February 6, 2015
Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategiesDickran Kazandjian, Sham Mailankody, Neha Korde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.
Blood|June 21, 2013
Pursuing the curative blueprint for early myelomaMark Roschewski, Neha Korde, S Peter Wu, et al.
Leukemia & Lymphoma|September 28, 2011
Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expressionPrashant Tembhare, Constance Yuan, Neha Korde, et al.
Leukemia & Lymphoma|August 14, 2012
Evolving therapeutic paradigms for multiple myeloma: back to the futureBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Minimal residual disease: what are the minimum requirements?Mark Roschewski, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.
Leukemia & Lymphoma|June 9, 2011
Current and future imaging modalities for multiple myeloma and its precursor statesEsther Tan, Brendan M Weiss, Esther Mena, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Current Hematologic Malignancy Reports|February 20, 2016
Smoldering Multiple Myeloma: Emerging Concepts and TherapeuticsSrinath Sundararajan, Abhijeet Kumar, Neha Korde, et al.
Clinical Advances in Hematology & Oncology : H&O|February 6, 2015
Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategiesDickran Kazandjian, Sham Mailankody, Neha Korde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.
Blood|June 21, 2013
Pursuing the curative blueprint for early myelomaMark Roschewski, Neha Korde, S Peter Wu, et al.
Leukemia & Lymphoma|September 28, 2011
Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expressionPrashant Tembhare, Constance Yuan, Neha Korde, et al.
Leukemia & Lymphoma|August 14, 2012
Evolving therapeutic paradigms for multiple myeloma: back to the futureBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Minimal residual disease: what are the minimum requirements?Mark Roschewski, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.
Leukemia & Lymphoma|June 9, 2011
Current and future imaging modalities for multiple myeloma and its precursor statesEsther Tan, Brendan M Weiss, Esther Mena, et al.
Pageof 13